Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Harry Erba, MD, PhD, Duke University, Durham, NC; Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY; Thomas Cluzeau, MD, PhD, Central University Hospital…
NEW YORK (Reuters Health) – Long-term results confirm that use of neoadjuvant chemotherapy in treating muscle-invasive cancer of the bladder confers a significant survival advantage, an international collaborative…
NEW YORK (Reuters Health) – In surgical patients at high risk of contaminated incisions, a simple protocol of daily wound probing reduces the rate of surgical site infections,…
NEW YORK (Reuters Health) – Vascular complication rates are higher with an antegrade rather than retrograde femoral approach to percutaneous endovascular procedures in the lower extremities, a Michigan…
NEW YORK (Reuters Health) – Ceftazidime and amikacin delivered by nebulizer is as effective as intravenous administration in treating ventilator-associated pneumonia (VAP) caused by Pseudomonas aeruginosa, and is…
NEW YORK (Reuters Health) – Contrary to previous findings, patients with advanced cancer do not have significantly improved survival when they are treated with a low-molecular-weight heparin, European…
NEW YORK (Reuters Health) – The risk of progression to AIDS in HIV-infected patients is significantly reduced when combined antiretroviral therapy is started at a CD4 count threshold…
NEW YORK (Reuters Health) – It is well established that sleep disordered breathing increases the risk of heart disease. It now appears that incident cardiovascular disease is associated…
NEW YORK (Reuters Health) – The combination of etanercept and cyclophosphamide might be a risky one in patients with Wegener’s Granulomatosis, especially with those who have long-term, chronic…
NEW YORK (Reuters Health) – A Phase III trial found that inhaled mannitol helped decrease respiratory symptoms in patients with cystic fibrosis. In the study, published in the…
Join us for our Abstract Highlights – AACE 2011 Conference – Long Term Effects of Denosumab in Postmenopausal Osteoporosis. Participants in the 2011 AACE annual meeting considered a…
